Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Maurizio Fava, M.D.

Co-Author

This page shows the publications co-authored by Maurizio Fava and Joel Pava.
Connection Strength

1.255
  1. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. J Clin Psychopharmacol. 2008 Dec; 28(6):660-6.
    View in: PubMed
    Score: 0.099
  2. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine. J Clin Psychopharmacol. 2004 Oct; 24(5):507-11.
    View in: PubMed
    Score: 0.074
  3. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Dec; 26(7-8):1415-9.
    View in: PubMed
    Score: 0.065
  4. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder. J Clin Psychopharmacol. 2002 Oct; 22(5):474-80.
    View in: PubMed
    Score: 0.064
  5. Predictors of stable personality disorder diagnoses in outpatients with remitted depression. J Nerv Ment Dis. 2002 Apr; 190(4):248-56.
    View in: PubMed
    Score: 0.062
  6. Early drop-outs, late drop-outs and completers: differences in the continuation phase of a clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2002 Apr; 26(3):415-9.
    View in: PubMed
    Score: 0.062
  7. Anxiety disorders in major depression. Compr Psychiatry. 2000 Mar-Apr; 41(2):97-102.
    View in: PubMed
    Score: 0.054
  8. Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study. J Affect Disord. 2000 Jan-Mar; 57(1-3):241-7.
    View in: PubMed
    Score: 0.053
  9. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999 Apr; 60(4):221-5.
    View in: PubMed
    Score: 0.051
  10. Course and treatment of atypical depression. J Clin Psychiatry. 1998; 59 Suppl 18:5-9.
    View in: PubMed
    Score: 0.046
  11. Major depressive subtypes and treatment response. Biol Psychiatry. 1997 Oct 01; 42(7):568-76.
    View in: PubMed
    Score: 0.046
  12. Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implications. Psychol Med. 1997 May; 27(3):627-33.
    View in: PubMed
    Score: 0.044
  13. Eating disorder symptomatology in major depression. J Nerv Ment Dis. 1997 Mar; 185(3):140-4.
    View in: PubMed
    Score: 0.044
  14. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes? Biol Psychiatry. 1996 Oct 15; 40(8):691-6.
    View in: PubMed
    Score: 0.043
  15. Patterns of personality disorder comorbidity in early-onset versus late-onset major depression. Am J Psychiatry. 1996 Oct; 153(10):1308-12.
    View in: PubMed
    Score: 0.043
  16. Gender differences in Axis I comorbidity among depressed outpatients. J Affect Disord. 1996 Jun 05; 38(2-3):129-33.
    View in: PubMed
    Score: 0.042
  17. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res. 1996 Jun 01; 62(3):213-9.
    View in: PubMed
    Score: 0.042
  18. Cardiovascular risk factors in depression. The role of anxiety and anger. Psychosomatics. 1996 Jan-Feb; 37(1):31-7.
    View in: PubMed
    Score: 0.040
  19. Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose. J Clin Psychiatry. 1995 Feb; 56(2):52-5.
    View in: PubMed
    Score: 0.038
  20. Integrating cognitive therapy and pharmacotherapy in the treatment and prophylaxis of depression: a novel approach. Psychother Psychosom. 1994; 61(3-4):211-9.
    View in: PubMed
    Score: 0.035
  21. Dysfunctional attitudes in major depression. Changes with pharmacotherapy. J Nerv Ment Dis. 1994 Jan; 182(1):45-9.
    View in: PubMed
    Score: 0.035
  22. Personality disorder comorbidity with major depression and response to fluoxetine treatment. Psychother Psychosom. 1994; 62(3-4):160-7.
    View in: PubMed
    Score: 0.035
  23. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment. Am J Psychiatry. 1993 Aug; 150(8):1158-63.
    View in: PubMed
    Score: 0.034
  24. Anger attacks in depressed outpatients and their response to fluoxetine. Psychopharmacol Bull. 1991; 27(3):275-9.
    View in: PubMed
    Score: 0.029
  25. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 2010 Mar-Apr; 51(2):124-9.
    View in: PubMed
    Score: 0.027
  26. Psychiatric comorbidity as a predictor of clinical response to nortriptyline in treatment-resistant major depressive disorder. J Clin Psychiatry. 2003 Nov; 64(11):1357-61.
    View in: PubMed
    Score: 0.017
  27. Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder. Biol Psychiatry. 1999 Jul 15; 46(2):202-11.
    View in: PubMed
    Score: 0.013
  28. Consumption of alcohol, nicotine, and caffeine among depressed outpatients. Relationship with response to treatment. Psychosomatics. 1996 Nov-Dec; 37(6):518-22.
    View in: PubMed
    Score: 0.011
  29. Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment. Am J Psychiatry. 1993 Aug; 150(8):1164-8.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.